Globugold 5% Injection contains Human Normal Immunoglobulin, is an Intravenous Immunoglobulin preparation used for the treatment for different immune deficiency disorders and autoimmune disorders.

Brand Name: Globugold

Composition: Human Normal Immunoglobulin

Mechanism of Action:

In immunocompromised patients, Globugold 5% Injection (IVIG) provides passive immunity by neutralizing germs and viruses with IgG antibodies. In autoimmune diseases, it stops platelets and other cells from being destroyed by blocking Fc receptors on immune cells. Additionally, IVIG uses anti-idiotypic antibodies to neutralize dangerous autoantibodies. By preventing complement activation, it lessens tissue damage and inflammation. In order to reduce aberrant immunological responses, it also increases regulatory T-cell activity and modifies cytokine levels.

Uses:

Immunodeficiency Disorders

Dosage and Administration:

Depending on the indication, patient weight, and clinical state, dosage and frequency can vary significantly.

Side Effects:

·       Fever

·       Chills

·       Headache

·       Nausea

·       Myalgia

·       Fatigue

·       Hypotension

·       Flushing

·       Chest tightness

·       Anaphylaxis

·       Acute renal failure

Safety Advise:

Lungs  

The safety of Globugold Injection for individuals with lung issues is uncertain. Kindly speak with your healthcare provider.

Liver  

The safety of Globugold Injection for individuals with liver issues is uncertain. Kindly speak with your healthcare provider.

Kidney  

The safety of Globugold Injection for individuals with Kidney issues is uncertain. Kindly speak with your healthcare provider.

Pregnancy  

Globugold should be used during pregnancy only if clearly needed, Kindly speak with your healthcare provider.

Breast Feeding  

Using Globugold while nursing is most likely dangerous. Kindly speak with your healthcare provider. 

Storage:

Globugold should be kept in the refrigerator between 2°C and 8°C (36°F and 46°F). The formulation may be harmed by freezing, so avoid doing so.

References:

1.     Wood P. Human normal immunoglobulin in the treatment of primary immunodeficiency diseases. Therapeutics and clinical risk management. 2012 Apr 2:157-67.

2.   Papadea C, Check IJ. Human immunoglobulin G and immunoglobulin G subclasses: biochemical, genetic, and clinical aspects. Critical reviews in clinical laboratory sciences. 1989 Jan 1;27(1):27-58.

3.    Cassidy JT, Nordby GL. Human serum immunoglobulin concentrations: prevalence of immunoglobulin deficiencies. Journal of Allergy and Clinical Immunology. 1975 Jan 1;55(1):35-48.

Disclaimer:

The main goal of Apothecare Wellness is to make sure that the information it provides to customers is correct, reliable, and reviewed by specialists. This website's contents and information are strictly for informational purposes. They are not meant to be used in place of expert medical advice, diagnosis, or care. Please consult your physician for guidance and ask any questions you may have about any condition or medication. If you read anything on Apothecare Wellness, do not discount or delay obtaining competent medical advice. Our goal is to enhance the doctor-patient relationship, not to take its place.

Marketer details

Name: Mankind Pharma Ltd

Address: 208, Okhla Industrial Estate, Phase III, New Delhi - 110020

Country of origin: India